发明名称 VACCINE COMPOSITION FOR USE IN IMMUNO-COMPROMISED POPULATIONS
摘要 The invention relates to nasally-administered vaccine compositions effective against infection in immuno-compromised populations. One aspect of the invention is directed to the pediatric use of the vaccine of the invention including a vaccine effective in children against seasonal influenza virus strains. A further aspect of the invention is directed to subjects of all age groups when the composition is for pandemic use.
申请公布号 US2015306204(A1) 申请公布日期 2015.10.29
申请号 US201314650807 申请日期 2013.12.17
申请人 EUROCINE VACCINES AB 发明人 Arwidsson Hans;Maltais Anna-Karin
分类号 A61K39/145;A61K39/39;C12N7/00 主分类号 A61K39/145
代理机构 代理人
主权项 1. A method of immunizing an immune-compromised subject against influenza for reducing virus shedding comprising: administering intranasally to an immuno-compromised subject a composition comprising: i) one or more non-live influenza virus antigen(s) selected from the group consisting of whole inactivated virus, split virus, subunit influenza antigen, and recombinant antigens, andii) an adjuvant comprising: one or more carboxylic acids,an aqueous medium, andone or more mono-glycerides.
地址 Solna SE